Skip to main content
. 2026 Oct 8;18(19):3239. doi: 10.3390/cancers18193239
OSA Osteosarcoma
ICI Immune checkpoint inhibitors
TME Tumor microenvironment
ADC Antibody–drug conjugates
CAR-T Chimeric antigen receptor-T-cell
CSPG4 Chondroitin sulfate proteoglycan 4
TLR2 Toll-like receptor 2
ECM Extracellular matrix
TAMs Tumor-associated macrophages
MDSCs Myeloid-derived suppressor cells
MSC Mesenchymal stem cells
NK Natural killer
DCs Dendritic cells
EMT Epithelial–mesenchymal transition
MMP-2 Matrix metalloproteinase-2
mAbs Monoclonal antibodies
I-DXd Ifinatamab deruxtecan
2D Two-dimensional
3D Three-dimensional
NSG NOD-scid IL2Rγnull
scRNA-seq single-cell RNA sequencing